Quick Answer
Biologic therapies target specific molecules in the immune system to reduce inflammation in rheumatoid arthritis. They are used when conventional DMARDs are insufficient.
Medically reviewed by Dr. Shree Narayan Yadav • NMC 14227 • Kathmandu Neurology Clinic & Cognitive Center
Biologic therapies represent a major advance in rheumatoid arthritis treatment. Unlike conventional DMARDs such as methotrexate, which have broad immunosuppressive effects, biologics are engineered proteins that target specific molecules involved in the inflammatory cascade. This targeted approach can achieve better disease control with potentially fewer side effects than broad immunosuppression.
The main classes of biologics for RA include TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab, golimumab), which block tumor necrosis factor, a key cytokine driving joint inflammation. IL-6 inhibitors (tocilizumab, sarilumab) block interleukin-6 signaling. T-cell co-stimulation inhibitors (abatacept) prevent immune cell activation. B-cell depleting agents (rituximab) reduce the number of B cells that produce autoantibodies. JAK inhibitors (tofacitinib, baricitinib, upadacitinib) are oral targeted synthetic DMARDs that block intracellular signaling pathways.
Dr. Shree Narayan Yadav — consultant physician & joint and autoimmune disease specialist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for rheumatoid arthritis.
Biologics are typically used when conventional DMARDs, most commonly methotrexate, have not achieved adequate disease control. Most biologics are administered as subcutaneous injections or intravenous infusions at regular intervals. Before starting biologic therapy, patients are screened for infections including tuberculosis and hepatitis B, as these medications can reactivate latent infections. Regular monitoring during treatment includes assessment of disease activity, infection screening, and monitoring for side effects.
The goal of biologic therapy is to achieve remission or low disease activity, preventing joint damage progression and maintaining function. Many patients experience significant improvement in pain, swelling, stiffness, and overall quality of life. Treatment decisions are made collaboratively between the rheumatologist and patient, weighing benefits, risks, and individual preferences.
This article is educational and does not replace individual medical advice.
Frequently asked questions
Answers reviewed by Dr. Jitendra Prasad Yadav • MBBS, MD (Internal Medicine), FICN (Neurology), FCNV, FIHM • NMC 8029
No. RA is an autoimmune inflammatory condition, while osteoarthritis is a degenerative wear-and-tear condition. RA causes symmetric joint inflammation and systemic symptoms; osteoarthritis typically affects weight-bearing joints with mechanical pain.
There is currently no cure for RA, but with early and appropriate treatment, many patients achieve remission or good disease control. The goal of modern treatment is to prevent joint damage and maintain function.
Migraine is a neurological condition; headache is one feature. Associated symptoms and functional impact are important for diagnosis.
Aura refers to visual, sensory, or speech symptoms that precede the headache in some people. Both types are migraine; the presence of aura may influence management discussion.
More: All FAQs → · Ask Dr. Jitendra →
Related articles
Rheumatoid Arthritis Overview: What Patients Need to Know
A comprehensive overview of rheumatoid arthritis — causes, symptoms, diagnosis, and modern treatment approaches for this common autoimmune joint disease.
When to See a Rheumatologist: Signs You Should Not Ignore
Which symptoms warrant a rheumatology referral — joint swelling, prolonged stiffness, unexplained fatigue, and positive autoantibody tests.
Autoimmune Disease Diagnosis: How Rheumatologists Piece the Puzzle Together
How rheumatologists diagnose autoimmune diseases using clinical features, blood tests, imaging, and the challenges of diagnosing overlapping conditions.
Medical Disclaimer
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.
References & Review
Reviewed by Dr. Jitendra Prasad Yadav • Last reviewed: 2026-09-04
- International Classification of Headache Disorders, 3rd edition (ICHD-3).
- Harrison's Principles of Internal Medicine — Neurology sections.
- American Academy of Neurology guidelines for selected conditions (where applicable).
Content is educational and aligns with standard medical references; individual evaluation may vary. External links provide context and do not imply endorsement.